The Joint (JYNT)
(Delayed Data from NSDQ)
$11.90 USD
+0.43 (3.75%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $11.91 +0.01 (0.08%) 4:26 PM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum C VGM
Brokerage Reports
0 items in cart
The Joint Corp. [JYNT]
Reports for Purchase
Showing records 1 - 20 ( 150 total )
Company: The Joint Corp.
Industry: Medical - HMOs
System Relatively Healthy; Refranchising Process Moving Slowly
Provider: Roth Capital Partners, Inc.
Analyst: KELLY G
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
36th Annual ROTH Conference Takeaways - Consumer Lifestyle
Provider: Roth Capital Partners, Inc.
Analyst: KELLY G
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Lifestyle- Notes From The Deer Valley Conference
Provider: Roth Capital Partners, Inc.
Analyst: KELLY G
Company: The Joint Corp.
Industry: Medical - HMOs
Optimized Entry and Exit Levels for JYNT 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: The Joint Corp.
Industry: Medical - HMOs
Smart To Pare Back Owned Biz and Refocus on Brand and Franchise System
Provider: Roth Capital Partners, Inc.
Analyst: KELLY G
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
More of the Same...Brand/Franchise Momentum On-Track; Owned Biz Lags
Provider: Roth Capital Partners, Inc.
Analyst: KELLY G